Výsledky vyhledávání - Juby A. Jacob‐Nara

  • Zobrazuji výsledky 1 - 17 z 17
Upřesnit hledání
  1. 1
    The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

    The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps Autor Claus Bachert, Alexandra Hicks, Simon Gane, Anju T. Peters, Philippe Gevaert, Scott D. Nash, Julie Horowitz, Harry Sacks, Juby A. Jacob‐Nara

    Vydáno 2024
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis

    Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis Autor Anju T. Peters, Martin Wagenmann, Jonathan A. Bernstein, Asif Khan, Scott D. Nash, Juby A. Jacob‐Nara, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Type 2 Inflammation and Asthma in Children: A Narrative Review

    Type 2 Inflammation and Asthma in Children: A Narrative Review Autor Nikolaos G. Papadopoulos, Leonard B Bacharier, Daniel J Jackson, A. Deschildre, Wanda Phipatanakul, Stanley J Szefler, Rebecca Gall, Olivier Ledanois, Juby A Jacob-Nara, Harry Sacks

    Vydáno 2024
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Disease Burden and Unmet Need in Eosinophilic Esophagitis

    Disease Burden and Unmet Need in Eosinophilic Esophagitis Autor Albert J. Bredenoord, Kiran Patel, Alain Schoepfer, Evan S. Dellon, Mirna Chehade, Seema S. Aceves, Jonathan M. Spergel, Brad Shumel, Yamo Deniz, Paul J. Rowe, Juby A. Jacob‐Nara

    Vydáno 2022
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52

    Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINU... Autor Claus Bachert, Asif Khan, Stella E. Lee, Claire Hopkins, Anju T. Peters, Wytske J. Fokkens, Amy Praestgaard, Amr Radwan, Scott D. Nash, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)

    Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) Autor Jorge Máspero, Martti Antila, A. Deschildre, Leonard B. Bacharier, Arman Altincatal, Elizabeth Laws, Eric Mortensen, Amr Radwan, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin

    Vydáno 2024
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study

    Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study Autor Alessandro Fiocchi, Wanda Phipatanakul, Robert S. Zeiger, Sandy Durrani, Jeremy Cole, Jérôme Msihid, Rebecca Gall, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin, Yi Zhang, Asif Khan

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline Autor Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira Lugogo, Philip G. Bardin, Martti Antila, David Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob‐Nara, Rebecca Gall, Yamo Deniz, Paul J. Rowe

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study

    Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study Autor Jorge Máspero, Guido Cardona, Patricia Schonffeldt, Alberto Tolcachier, Sandra Nora González Díaz, Anahí Yáñez, Clóvis Eduardo Santos Galvão, Jérôme Msihid, Rebecca Gall, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz, Juby A. Jacob‐Nara, Michel Djandji

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study

    Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study Autor Leonard B. Bacharier, Theresa W. Guilbert, Constance H. Katelaris, A. Deschildre, Wanda Phipatanakul, Dongfang Liu, Arman Altincatal, Leda Mannent, Nikhil Amin, Elizabeth Laws, Bolanle Akinlade, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma

    Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma Autor Nikolaos G. Papadopoulos, Stanley J. Szefler, Leonard B. Bacharier, Jorge Máspero, Christian Domingo, Alessandro Fiocchi, Jason K. Lee, Nadia Daizadeh, David J. Lederer, Megan Hardin, Rebecca Gall, Michel Djandji, Shahid Siddiqui, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines

    Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines Autor Michael E. Wechsler, Adelmir Souza‐Machado, Christine Xu, Xuezhou Mao, Upender Kapoor, Faisal A. Khokhar, John T. O’Malley, Christopher D. Petro, Veronica Mas Casullo, Leda Mannent, Paul J. Rowe, Juby A. Jacob‐Nara, Marcella Ruddy, Elizabeth Laws, Lisa A. Purcell, Megan Hardin

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis Autor Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan, Robert R. Johnson, Upender Kapoor, Faisal A. Khokhar, Nadia Daizadeh, Zhen Chen, Elizabeth Laws, Benjamin Ortiz, Juby A. Jacob‐Nara, Leda Mannent, Paul J. Rowe, Yamo Deniz

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

    Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma Autor Ian Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle, Nami Pandit‐Abid, Arman Altincatal, Zhen Chen, Nikhil Amin, Asif Khan, David J. Lederer, Yi Zhang, Paul J. Rowe, Yamo Deniz, Amr Radwan, Juby A. Jacob‐Nara, William W. Busse

    Vydáno 2024
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

    Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction Autor Nicola A. Hanania, Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald, Jorge Máspero, Constance H. Katelaris, Dave Singh, Nadia Daizadeh, Arman Altincatal, Nami Pandit‐Abid, Xavier Soler, Shahid Siddiqui, Elizabeth Laws, Juby A. Jacob‐Nara, Paul J. Rowe, David J. Lederer, Megan Hardin, Yamo Deniz

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma

    Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma Autor Daniel J. Jackson, Leonard B. Bacharier, Wanda Phipatanakul, Lawrence Sher, Christian Domingo, Nikolaos G. Papadopoulos, Brian D. Modena, Ning Li, Changming Xia, Mohamed Kamal, Myles Dillon, Kelley Wolfe, Rebecca Gall, Nikhil Amin, Leda Mannent, Elizabeth Laws, Paul J. Rowe, Juby A. Jacob‐Nara, Yamo Deniz, David J. Lederer, Megan Hardin, Christine Xu

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial

    Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial Autor Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira Lugogo, Christopher E. Brightling, Francisco Javier González‐Barcala, Arnaud Bourdin, Мykola Ostrovskyy, Maria Staevska, P I Chou, Liliana Duca, Ana Pereria, Charles Fogarty, Rufai Nadama, Mei Zhang, Amelie Rodrigues, Xavier Soler, Simona Pantelimon, Harry Sacks, Yamo Deniz, Paul Rowe, Lucía De Prado Gómez, Juby A. Jacob‐Nara

    Vydáno 2024
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: